21 CFR Part 516 - Subpart C - Index of Legally Marketed Unapproved New Animal Drugs for Minor Species

prev | next
  1. § 516.111 Scope of this subpart.
  2. § 516.115 Definitions.
  3. § 516.117 Submission of correspondence under this subpart.
  4. § 516.119 Permanent-resident U.S. agent for foreign requestors and holders.
  5. § 516.121 Meetings.
  6. § 516.123 Informal conferences regarding agency administrative actions.
  7. § 516.125 Investigational use of minor species new animal drugs to support indexing.
  8. § 516.129 Content and format of a request for determination of eligibility for indexing.
  9. § 516.131 Refuse to file a request for determination of eligibility for indexing.
  10. § 516.133 Denying a request for determination of eligibility for indexing.
  11. § 516.135 Granting a request for determination of eligibility for indexing.
  12. § 516.137 Notification of decision regarding eligibility for indexing.
  13. § 516.141 Qualified expert panels.
  14. § 516.143 Written report.
  15. § 516.145 Content and format of a request for addition to the index.
  16. § 516.147 Refuse to file a request for addition to the index.
  17. § 516.149 Denying a request for addition to the index.
  18. § 516.151 Granting a request for addition to the index.
  19. § 516.153 Notification of decision regarding index listing.
  20. § 516.155 Labeling of indexed drugs.
  21. § 516.157 Publication of the index and content of an index listing.
  22. § 516.161 Modifications to indexed drugs.
  23. § 516.163 Change in ownership of an index file.
  24. § 516.165 Records and reports.
  25. § 516.167 Removal from the index.
  26. § 516.171 Confidentiality of data and information in an index file.
Source:
72 FR 69121, Dec. 6, 2007, unless otherwise noted.